Replicate’s srRNA rabies vaccine effective in Phase 1
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: Congress
STAT+: Lawmakers eye partial increase for Medicare doctor pay
WASHINGTON — Lawmakers are considering increasing doctors’ Medicare pay in an upcoming government funding package,…
STAT+: Judge tosses PhRMA lawsuit over Medicare power to negotiate drug prices
WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss…
No one’s pleased with the government’s pitch for 2025 Medicare Advantage rates
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
STAT+: Senators start work on Medicare physician payment reform
WASHINGTON — A bipartisan group of senators is starting work on legislation to reform how…
Does Moderna’s RSV vaccine lose efficacy faster than others?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Key House Republican on health care plans exit from Congress
WASHINGTON — Rep. Cathy McMorris Rodgers, the chair of a crucial House committee that handles…
In a showy hearing, Bernie Sanders gets few answers about lower drug prices
WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater. The hearing, featuring Merck…
Gilead sours on the ‘don’t eat me’ business
Want to stay on top of the science and politics driving biotech today? Sign up to get…
New pharma CEOs in the hot seat
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: House panel passes key PBM reform for sliver of commercial market
WASHINGTON — A House panel passed a bipartisan bill to ban drug middlemen from charging…
CDC and social media: The new misinformation war
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: The lone Democrat willing to weaken Medicare’s power to negotiate drug prices
WASHINGTON — Two Republican lawmakers who introduced legislation to water down the Inflation Reduction Act’s…
Let the Medicare Advantage lobbying begin
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
Medical devices with screens aren’t accessible to the blind. Congress has chance to change that
Katie Keim was diagnosed with type 1 diabetes in 1967 when she was eight, well…
STAT+: Senate working group proposes 340B reforms
WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial…
Opinion: Medicare has different standards than the FDA. That’s how it should be
Who among us is looking forward to getting older in 2024? Not senators (most of…
Medicare drug price negotiation’s day in court
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Congressmen: This Covid hearing ‘could have been an email’
WASHINGTON — House Republicans have repeatedly accused Biden health officials of withholding and censoring documents…
STAT+: FDA’s Woodcock reflects on more than 30 years at agency — and hints at what’s next
WASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime…
23andMe breach targeted Chinese, Jewish populations
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Merck, Johnson & Johnson CEOs agree to testify in Congress on high drug prices, avoiding Bernie Sanders’ subpoena
WASHINGTON — Merck CEO Robert Davis and Johnson and Johnson CEO Joaquin Duato have agreed…
Opinion: Congress must pass the child tax credit deal to support kids’ health
When I enter, “what is pediatrics?” into an image search engine, I get back dozens…
STAT+: Democrats urge government to rein in Medicare Advantage overpayments and denials
The Biden administration is about to set the ground rules for next year’s Medicare Advantage…
Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says
WASHINGTON — Sen. Bernie Sanders on Thursday jabbed the CEO of Merck for telling congressional…
Zyn scrutiny from Sen. Chuck Schumer prompts an unlikely culture war
Senate Majority Leader Chuck Schumer (D-N.Y.) wants the federal government to investigate Zyn nicotine pouches….
Bernie Sanders’ showdown with pharma CEOs is coming to a head
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Key Senate panel considers Medicare bonuses for hospitals that prevent drug shortages
WASHINGTON — A key Senate committee is proposing that Medicare pay bonuses to hospitals that…
White House pharmacy under the microscope
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
The Senate health committee looks into its first subpoena in 40 years
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices
WASHINGTON — Senate health committee chair Bernie Sanders has taken a step toward subpoenaing the…
STAT+: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension
WASHINGTON — Negotiations to add extra health care policies to Congress’ stopgap funding bill fell…
Opinion: The decline and fall of elite multispecialty medical groups
The failure of Geisinger Health System, which lost $842 million in 2022 and disappeared into…
The state of Medicare Advantage, in one chart
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
Health care negotiations on Capitol Hill are clear as mud
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
The four biotech stories you need to read this morning
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: The new NIH director is walking a tightrope on Biden’s drug pricing vision
WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally…
STAT+: Could private equity be the future of private practice? A new lobbying group thinks so
Private equity gets a bad rap in health care. But some doctors see that kind…
STAT+: Fiery MedPAC meeting highlights massive overpayments in Medicare Advantage
Medicare Advantage is arguably the most controversial health care program right now — a sentiment…
STAT+: Courts will decide the future of Medicare’s power to negotiate drug prices within months
WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare…
After grilling Fauci on Covid origins, House Republicans want to consider new rules for foreign research
WASHINGTON — House Republicans want to explore tighter inspection and safety requirements for infectious disease…
Anthony Fauci talked Covid in Congress in a nine-hour, closed-door grilling — and that was just day one
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Opinion: Sen. Maggie Hassan on what Congress must do next to fight the opioid crisis
Few public health challenges have been more daunting and persistent than the opioid crisis, which…
STAT+: Sen. Sanders, others lawmakers open probe into asthma inhaler makers over pricing, patent maneuvers
Several U.S. lawmakers including Sen. Bernie Sanders (I-Vt.) are investigating the prices charged by four…
STAT+: HHS names inaugural chief competition officer
The Department of Health and Human Services will name Stacy Sanders as its new chief…
At JPM, how much health policy talk should we expect?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
An ugly fight over care for the poor in Texas
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Venture capital is still pouring into drug research despite Medicare price negotiation
WASHINGTON — Venture capitalists are still pouring money into drug research in spite of Medicare’s…
STAT+: Sanders blames food companies for diabetes epidemic
WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry. Sanders…
Morning Rounds: Can you take GLP-1 drugs during pregnancy?
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…